ENTrigue Surgical
Founded Year
2007Stage
Acquired | AcquiredTotal Raised
$30.67MValuation
$0000Revenue
$0000About ENTrigue Surgical
ENTrigue Surgical is an early commercial stage company that is developing several product platforms for the relatively underserved Ears, Nose, & Throat market. The company was founded in 2007 by an ENT surgeon (Dr. Donald Gonzales) and medical device industry executive (Fred Dinger). Among ENTrigue's first commercialized products are a line of articulating instruments; a septal stapling system utilizing resorbable staples; and a line of resorbable suture and tissue repair products based on a new class of polymers with a profile of strength, flexibility, and soft tissue compatibility that is when compared to existing resorbable polymers. In July 2013, ENTrigue Surgical was acquired by ArthroCare. The valuation of ENTrigue Surgical was $45 million. Other terms of the deal were not released.
Missing: ENTrigue Surgical's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: ENTrigue Surgical's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
ENTrigue Surgical Patents
ENTrigue Surgical has filed 10 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
2/10/2015 | 5/23/2017 | Inflammations, Nose, Implants (medicine), Bones of the head and neck, Syndromes | Grant |
Application Date | 2/10/2015 |
|---|---|
Grant Date | 5/23/2017 |
Title | |
Related Topics | Inflammations, Nose, Implants (medicine), Bones of the head and neck, Syndromes |
Status | Grant |
Latest ENTrigue Surgical News
Mar 11, 2017
ENTrigue Surgical, Inc. Medical Equipment Deals and Alliances Profile [Updated: 23012017] Prices from USD $250 21:07 EST 10 Mar 2017 | BioPortfolio Reports Home » Topics » Surgical treatments » Latest News » ENTrigue Surgical, Inc. Medical Equipment Deals and Alliances Profile [Updated: 23012017] Prices from USD $250 Summary ENTrigue Surgical , Inc. ENTrigue is a medical device company that designs, develops and manufactures surgical instruments. The company offers products such as sinus dilation system, septal staplers, hemostatic gels, and articulating instruments. Its articulating instruments comprise vertical jaw articulating thrucutting forceps, horizontal jaw articulating thrucutting forceps, vertical jaw articulating grasping forceps and horizontal jaw articulating grasping forceps. The company offers sinus dilation systems such as sinus delivery instruments and sinus dilation balloons. It sells its products through a network of distributors in the US and abroad. ENTrigue is headquartered in San Antonio, Texas, the US. ENTrigue Surgical, Inc. Medical Equipment Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News
ENTrigue Surgical Frequently Asked Questions (FAQ)
When was ENTrigue Surgical founded?
ENTrigue Surgical was founded in 2007.
Where is ENTrigue Surgical's headquarters?
ENTrigue Surgical's headquarters is located at 12672 Silicon Drive, San Antonio.
What is ENTrigue Surgical's latest funding round?
ENTrigue Surgical's latest funding round is Acquired.
How much did ENTrigue Surgical raise?
ENTrigue Surgical raised a total of $30.67M.
Who are the investors of ENTrigue Surgical?
Investors of ENTrigue Surgical include ArthroCare Corporation, Prism VentureWorks, The Vertical Group and TauTona Group.
Who are ENTrigue Surgical's competitors?
Competitors of ENTrigue Surgical include NICO, Biorez, Tepha, MedShape, REGENESIS BIOMEDICAL and 15 more.
Compare ENTrigue Surgical to Competitors
Connective Orthopaedics is a medical device company focused on the repair of soft tissue injuries.
Tissue Regeneration Systems (TRS) is commercializing a skeletal reconstruction and bone reconstruction technology for the fabrication of bioresorbable implants. These implants fully replace themselves with natural bone over time, leaving no residual implanted device; moreover, although the micro-architecture of these implants is porous for the facilitation of bone integration, they can nonetheless bear load and are strong enough to support function without the need for reinforcement from metal plates. Such structural integrity enables them to be used as an alternative to harvested, autologous bone that is fixed with metallic plates for complex skeletal reconstruction. TRS implants are also integrated with an osteoconductive coating that enhances bone regeneration and proliferation; powerful orthobiologics and bone-growing autologous cells will readily bind to this coating, allowing for a controlled biologic release to further accelerate bone formation.
Pegasus Biologics is developing advanced bioimplants for soft tissue reinforcement for orthopedics, sports medicine, neurosurgical and spine applications
Claros Diagnostics is an early stage device company developing a POC multiplex diagnostic focused on a biomarker panel for prostate cancer.
Regenesis is engaged in the development, manufacturing, and sale of biomedical devices that promote healing and skin wound closure more quickly and cost-effectively than existing standards of wound treatment. The company's devices are based on its Cell Proliferation Induction (CPI) technology, in which electromagnetic signals trigger the repair and regeneration of soft tissue cells.
NICO develops technology for the field of minimally invasive neurosurgery, including skull base and spinal surgery. The company's technology and products are designed and developed to impact patients' lives, families, caregivers, and health system providers. It provides patented technologies that integrate imaging and intervention for approaches to brain surgery. NICO was founded in 2007 and is based in Indianapolis, Indiana.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.